About Raymond Kelleher
Raymond Kelleher is a director at BridgeBio Oncology Therapeutics.
Form D filings name Raymond Kelleher as a director at TheRas.
Raymond Kelleher reports to the SEC as a director of 1 public company.
Raymond Kelleher first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Raymond Kelleher in the role, so the role may have started earlier or lasted longer.
BI
BridgeBio Oncology Therapeutics, Inc.
Director
2025 – 2026 · Public company (BBOT)
Key Colleagues at Startups
The people Raymond Kelleher works with at each company, as listed on that company's latest Form D.
TheRas, Inc. · Form D, May 15, 2024
MD
Michelle Doig
Director
IE
Idan Elmelech
Executive officer
PB
Pedro Beltran
Executive officer
FM
Frank McCormick
Director
NK
Neil Kumar
Director
EW
Eli Wallace
CEO